← Back to headlines
Biogen Faces Italian Antitrust Probe Over MS Drug Rivalry with Sandoz
Biogen is facing an antitrust probe in Italy concerning its rivalry with Sandoz over multiple sclerosis drugs. The investigation will examine potential anti-competitive practices in the pharmaceutical market.
27 May, 11:27 — 27 May, 11:27
Sources
Showing 1 of 1 sources
Related Stories
Trump Considers Military Action Against Iran Amid Hormuz Blockade Discussions; UK Declines to Join
just now
Davao City Mayor Orders Garbage Dumped Outside DENR Office Amid Crisis
just now
DENR warns against garbage dumping outside Davao office
just now
Philippine Civil Society Network Calls for Stronger Support for Out-of-School Youth and Teachers
just now